MannKind Corp: Of The Original Report To Include The Audited Consolidated Financial Statements Of Scpharma (as Defined In The Original Report) As Of And For The Year Ended December 31, 2024 And To Include The Unaudited Interim Condensed Consolidated Financial Statements Of Scpharma As Of And For The Three And Six Months Ended June 30, 2025; And (ii) Update The Information In Item 9.01(b) Of The Original Report To Include The Unaudited Pro Forma Condensed Combined Financial Information Of The Company As Of And For The Six Months Ended June 30, 2025 And The Year Ended December 31, 2024. This Amendment No. 1 Does Not Amend Any Other Item Of The Original Report Or Purport To Provide An Update Or A Discussion Of Any Developments At The Company Subsequent To The Filing Date Of The Original Report

Show full article

This functionality is available for registred users only

• Full name
  MannKind Corporation
• Registration country
  USA
• Industry
  Pharmaceutical Preparation and Biotechnology
• М/S&P/F
  *** / *** / ***